Percentage of Participants With Composite Efficacy Failure at 12 Months [clinicaltrials_resource:NCT00300274/outcome/1]
outcome [clinicaltrials_vocabulary:outcome]
Percentage of Participants With Composite Efficacy Failure at 12 Months [clinicaltrials_resource:NCT00300274/outcome/1]
Bio2RDF identifier
NCT00300274/outcome/1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00300274/outcome/1
group [clinicaltrials_vocabulary:group]
measure [clinicaltrials_vocabulary:measure]
population [clinicaltrials_vocabulary:population]
IVUS population consisted of r ...... from Month 12 (IVUS Centers).
IVUS population consisted of r ...... from Month 12 (IVUS centers).
Intent-to-treat population included all randomized participants.
Intent-to-treat population includes all randomized participants.
Participants from the intent-t ...... h data available for analysis.
safety issue [clinicaltrials_vocabulary:safety-issue]
time frame [clinicaltrials_vocabulary:time-frame]
Baseline, Month 12
type [clinicaltrials_vocabulary:type]
alternate
Percentage of Participants With Composite Efficacy Failure at 12 Months
@en
identifier
clinicaltrials_resource:NCT00300274/outcome/1
title
Composite efficacy failure was ...... or use of inotropic treatment.
@en
type
label
Percentage of Participants Wit ...... esource:NCT00300274/outcome/1]
@en